Tag: COPD
Health Expenditures Considerable for Asthma, COPD in U.S. Workers
Annualized total medical expenditures are $7 billion and $5 billion, respectively
Triple Inhaled Therapy Aids in Moderate-to-Very Severe COPD
Benefit seen for twice-daily triple inhaled therapy with glucocorticoid, glycopyrrolate, formoterol
Dysanapsis Measured on CT Associated With COPD in Seniors
Incidence of COPD was significantly higher in lowest versus highest quartile of airway-to-lung ratio
Guideline Details Pharmacologic Management of COPD
Clinical practice guideline addresses six emerging questions around COPD management
Pulmonary Rehab Associated With Lower COPD Mortality
Only 1.5 percent of patients initiated pulmonary rehabilitation within 90 days of discharge
Asthma, COPD Medication Adherence Up During Pandemic
Authors say increased adherence may reflect patient concern about controlling primary respiratory illness
Risk for Severe COVID-19 May Be Up in People With COPD, Smokers
COPD patients, smokers have up-regulation of ACE-2, the cellular entry receptor for SARS-CoV-2
COPD Independent Risk Factor for Lung Cancer
Risk for lung cancer higher for never smokers with COPD, ever smokers with or without COPD
Triple Therapy Cuts Mortality in Patients With Symptomatic COPD
All-cause mortality risk significantly lower for triple-drug regimen versus one of two dual-drug regimens
Spirometry Suggests COPD for Many at Lung Cancer Screening
57 percent have spirometry findings consistent with COPD, 67 percent do not have prior history of COPD
